<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02432898</url>
  </required_header>
  <id_info>
    <org_study_id>Topcon-001-2014</org_study_id>
    <nct_id>NCT02432898</nct_id>
  </id_info>
  <brief_title>Non-Invasive Imaging of the Human Eye</brief_title>
  <official_title>Non-Invasive Imaging of the Human Eye</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Topcon Medical Systems, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Topcon Medical Systems, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the clinical information obtained from the use of the machines.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluate the clinical information provided by these devices and determine their clinical
      utility and efficacy and safety.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No subjects were enrolled in this protocol
  </why_stopped>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Device Evaluation</measure>
    <time_frame>1 Hour</time_frame>
    <description>Determine Clinical Utility, Efficacy, and Safety</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Willing and Able Subjects for Ocular Imaging</condition>
  <arm_group>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
    <description>Normal healthy eyes with no known ocular diseases</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D OCT-1</intervention_name>
    <description>Spectral Domain OCT Device</description>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D OCT-2000</intervention_name>
    <description>Spectral Domain OCT Device</description>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DRI OCT-1</intervention_name>
    <description>Swept Source OCT Device</description>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NW-300</intervention_name>
    <description>Fundus Camera</description>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CT-1P</intervention_name>
    <description>Tonometry</description>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TRK-2P</intervention_name>
    <description>Tonometry, Corneal Topography</description>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SP-1P</intervention_name>
    <description>Specular Microscopy</description>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SL-D701</intervention_name>
    <description>Slit Lamp Imaging</description>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MC-4S</intervention_name>
    <description>Visual Acuity Testing</description>
    <arm_group_label>Normal Healthy Eyes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Normal subjects will be recruited from Topcon Medical Systems.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female patients from 18 to 80 years old who have full legal capacity to
             volunteer on the date the informed consent is signed.

          2. Subjects who can follow the instructions by the clinical staff at the clinical site
             and can attend examinations on the scheduled examination date.

        Exclusion Criteria:

          1. History of ocular pathology.

          2. History of cataract of ocular surgical procedures that render the cornea opaque or
             otherwise impact its ability to be imaged using the investigational device.

          3. History of systemic disease

          4. fixation problems which may prevent obtaining good quality images in the eye.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danny Leung</last_name>
    <role>Principal Investigator</role>
    <affiliation>Topcon Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Topcon Medical Systems, Inc.</name>
      <address>
        <city>Oakland</city>
        <state>New Jersey</state>
        <zip>07436</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2014</study_first_submitted>
  <study_first_submitted_qc>April 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2015</study_first_posted>
  <last_update_submitted>November 1, 2016</last_update_submitted>
  <last_update_submitted_qc>November 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

